Combined Therapy with Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers is the Treatment of Choice to Reduce Cardiovascular Risk in Patients with Hypertension

pp 295-303

Authors

  • Guillermo Fabregués Full Member of the Sociedad Argentina de Cardiología. Specialist in Cardiology, Fundación Favaloro. Vice President, Fundación Cardiológica Argentina. Ex Director, Argentine Council of Hypertension Argentine Society of Cardiology.

DOI:

https://doi.org/10.7775/s961yg36

Published

2026-01-06

Issue

Section

CONTROVERSIAS

Most read articles by the same author(s)